Identification of the Hind III Polymorphic Site in the PAI-1 Gene: Analysis of the PAI-1 Hind III Polymorphism by PCR
- 19 March 2000
- journal article
- research article
- Published by Mary Ann Liebert Inc in Genetic Testing
- Vol. 4 (1) , 65-68
- https://doi.org/10.1089/109065700316507
Abstract
The identification of the Hind III polymorphic site in the 3' end of the plasminogen activator inhibitor 1 (PAI-1) gene and a simple method to identify the Hind III polymorphism rapidly in the PAI-1 gene using PCR is described. The Hind III restriction site was identified by restriction site mapping and sequence analysis from a cosmid DNA clone. Genomic DNA was isolated from individual human umbilical cords and a 754-bp fragment of the human PAI-1 gene was amplified by PCR. Aliquots of the PCR products were digested with Hind III and analyzed by agarose gel electrophoresis. The presence of two fragments, 754 and 567 bp, was identified, and they were designated as 1/1 (750-bp band), 1/2 (754- and 567-bp bands), and 2/2 (567-bp band). The PCR method is considerably less time consuming than the conventional DNA genotyping using Southern blot analysis. To ensure that this new method identified the same PAI-1 genotypes as previously identified by Hind III restriction fragment length polymorphism (RFLP), samples were simultaneously genotyped by PCR and Southern blot analysis. Both methods identified the same Hind III genotypes in all the samples, confirming the reliability of this new PCR method for the rapid identification of the Hind III polymorphism in the human PAI-1 gene.Keywords
This publication has 13 references indexed in Scilit:
- Gene Polymorphisms for Plasminogen Activator Inhibitor-1/Tissue Plasminogen Activator and Development of Allograft Coronary Artery DiseaseCirculation, 1998
- Genotype-Specific Transcriptional Regulation of PAI-1 Gene by Insulin, Hypertriglyceridemic VLDL, and Lp(a) in Transfected, Cultured Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- The PAI-1 Gene Locus 4G/5G Polymorphism Is Associated With a Family History of Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Identification of a BamHI Polymorphism for the Urokinase Gene Associated with Symptomatic Coronary Artery DiseaseJournal of Thrombosis and Thrombolysis, 1998
- Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery DiseaseJournal of Thrombosis and Thrombolysis, 1998
- A NOVEL G/A AND THE 4G/5G POLYMORPHISM WITHIN THE PROMOTER OF THE PLASMINOGEN ACTIVATOR INHIBITOR-1 GENE IN PATIENTS WITH DEEP VEIN THROMBOSISThrombosis Research, 1996
- Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population: the Paris Prospective Study, 15-year follow-upDiabetologia, 1991
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.Proceedings of the National Academy of Sciences, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985